Innova Captab Limited is making waves in the financial markets with its upcoming IPO on the NSE and BSE Exchange. With an issue size of Rs 570 Cr, including a fresh issue of Rs 320 Cr and an offer for sale (OFS) of Rs 250 Cr, this event is grabbing the attention of investors and market watchers alike.
Set to open between December 21st and 26th, 2023, the IPO offers a price band of Rs 426 to Rs 448 per share. I’ll be diving into the details, discussing the potential impacts on the market, and providing insights into the financials of Innova Captab Limited. Stay tuned for a thorough analysis that could help you make an informed decision about this significant financial milestone.
Innova Captab IPO Details
When it comes to the financial prospects of an IPO, potential investors need to have accurate and detailed information. I’ve gathered the essential details regarding Innova Captab Limited’s IPO to help you understand the investment opportunity at hand.
The IPO dates are critical, and for Innova Captab, the window to make your move falls between December 21st and December 26th, 2023. It’s a narrow timeframe, suggesting that preparation is key for those looking to acquire a stake. This mainboard IPO will list on both the NSE and BSE, expanding its reach to a wider investor audience.
Diving into specifics, interested parties should note that each share carries a face value of ₹10. With a price band setting between ₹426 and ₹448 per share, it’s important to assess the investment against your risk tolerance and return expectations.
Let’s talk numbers. The Lot Size for this IPO stands at 33 shares, which means you’ll need to purchase at least this number to participate. Here’s a quick breakdown of the issue specifics:
|Total Issue Size
|Offer for Sale
|Book Built Issue
|Shares Aggregating up to ₹570.00 Cr
|Shares Aggregating up to ₹320.00 Cr
|5,580,357 Shares Aggregating up to ₹250.00 Cr
Shareholding pre-issue stands at 50,082,072 shares, a figure that offers a glimpse into the company’s standing before the public gets a chance to claim a share of the pie.
If I can impart one piece of advice, it would be to keep abreast of the latest information regarding Innova Captab’s financial performance and projections. Understanding a company’s fundamentals, including its asset base, revenue streams, and profit margins, is crucial when considering any stock, let alone an IPO.
Innova Captab IPO Timeline
In the ever-evolving world of finance, timely information is king. Staying updated on IPO timelines is crucial, and that’s just what I aim to provide you with regarding the Innova Captab Limited IPO. The timeline begins with the opening of the IPO subscriptions on Thursday, December 21, 2023. Those looking to invest should mark their calendars because the window for this opportunity will close just after the Christmas holiday, on Tuesday, December 26, 2023.
For those who’ve invested in IPOs before, you know the process doesn’t just end when you hit the submit button on your application. There are a few key dates post-submission that you’ll want to keep an eye on. After the closing date, the basis of allotment will occur on Wednesday, December 27, 2023. It’s a date that determines who gets how many shares, and it’s as important as the initial opening date.
|Basis of Allotment
|Wednesday, December 27, 2023
|Initiation of Refunds
|Thursday, December 28, 2023
|Credit of Shares to Demat
|Thursday, December 28, 2023
|Friday, December 29, 2023
On Thursday, December 28, 2023, two things happen: refunds will be initiated for the unfortunate who didn’t get a piece of the pie, and shares will be credited to the Demat accounts of those who did. Finally, the much-anticipated moment of listing is set for the very next day, Friday, December 29, 2023, when Innova Captab Limited’s shares make their debut on the stock exchange floors. Keep in mind, that the cut-off time for UPI mandate confirmation is 5 PM on the closing date. Missing this could mean missing out on the IPO itself.
Remember, getting into an IPO isn’t just about that initial buy-in. It’s also about making sure you’re on top of each subsequent step in the process so that you can maximize your chances of coming out ahead. Whether you’re a seasoned investor or new to the game, understanding this timeline can make all the difference in your IPO experience with Innova Captab Limited.
Innova Captab IPO Lot Size
Investing in IPOs requires understanding the lot size, and with Innova Captab Limited’s upcoming offering, potential investors are curious about how many shares they can buy. The term “lot size” refers to the minimum number of shares you can apply for in an IPO. In my recent deep dive into the specifics, I found that the details for this IPO are quite clear.
Retail investors have flexibility when it comes to lot size. The minimum investment starts at one lot consisting of 33 shares, which means the lowest amount you’d have to invest would be ₹14,784. For those looking to invest more, the maximum limit for retail investors is set at 13 lots, translating to 429 shares and a total investment of ₹192,192.
For high-net-worth individuals (HNIs), there are two categories based on the investment size: small HNIs (S-HNIs) and big HNIs (B-HNIs). S-HNIs can apply for a minimum of 14 lots (462 shares) costing ₹206,976 and go up to a maximum of 67 lots (2,211 shares) for ₹990,528. B-HNIs, on the other hand, have a minimum application size of 68 lots, which comprises 2,244 shares and requires an investment of at least ₹1,005,312.
Here’s a consolidated view of the minimum and maximum lot sizes and investment amounts:
|Min Investment (₹)
|Max Investment (₹)
Innova Captab IPO Promoter Holding
As investors eye the Innova Captab Limited IPO, understanding the dynamics of promoter holdings is crucial. Manoj Kumar Lohariwala and Vinay Kumar Lohariwala hold the reins as the principal promoters of the company. With their guidance, the company has navigated through the competitive pharmaceutical landscape, yielding a diverse portfolio of products.
Before the IPO, these promoters held a substantial stake in the company, amounting to an impressive 66.85%. However, with the IPO’s progression, there’ll be a notable change in their shareholding pattern. The promoter’s shareholding post-Issue is poised to undergo a reduction, though precise figures are yet to be disclosed.
|Pre Issue (%)
|Post Issue (%)
The strategic decision to realign their holdings through the IPO involves an offer for sale (OFS) component, including promoters among the selling shareholders. This OFS of up to 55.80 lakh equity shares ensures that the company maintains a buffer for funding future innovations while also adhering to market regulations about promoter shareholding limits.
Prospective investors should closely monitor how this shift in promoter holding could influence the company’s governance and strategy in the long run. With the fresh issue of equity shares and OFS on the table, Innova Captab Limited signals a transformative phase in its entrepreneurial journey, inviting public investment to fuel its next growth chapter.
It’s important to note the pivotal role that these promoter holdings play in potential investor decisions. Their initial heavy involvement provided stability and likely guided the company’s strategy. As public stakeholders step in, the business structure might evolve, possibly impacting the decision-making and future company trajectory.
Innova Captab IPO Financial Information
Exploring a company’s financial health is critical before making any investment decisions. Innova Captab Limited has shown significant growth over the recent financial periods. Let’s dive into some numbers that highlight their financial trajectory.
The table below encapsulates the financial performance of Innova Captab leading up to the IPO:
|Assets (₹ Cr)
|Revenue (₹ Cr)
|Profit After Tax (₹ Cr)
|Net Worth (₹ Cr)
|Reserves and Surplus (₹ Cr)
|Total Borrowing (₹ Cr)
|30 Jun 2023
|31 Mar 2023
|31 Mar 2022
|31 Mar 2021
This data shows that there’s been a steady increase in assets and net worth, indicating robust growth and potentially a solid investment ground.
Revenue and Profit After Tax (PAT) also reflect the company’s ability to generate income and manage its expenses effectively. Though there was a noticeable dip in revenue for the period ending 30 Jun 2023, the uptrend over the years remains intact.
Looking at the Total Borrowings of Innova Captab Limited is equally important. A discernible hike in borrowings in Jun 2023 to ₹441.90 crore from ₹235.19 crore in Mar 2023 suggests increased financial leverage, which might have been a strategic move to fuel growth or expansion efforts.
Innova Captab IPO Reservation
When exploring the Innova Captab IPO, potential investors should be aware of the share reservation specifics. The IPO reservation structure is designed to cater to different categories of investors, ensuring a more balanced and fair allocation process. I’ll delve into the share distribution and point out essential details for each investor category.
The shares offered are divided into three significant categories: Qualified Institutional Buyers (QIBs), Retail Individual Investors (RIIs), and Non-Institutional Investors (NIIs), which further includes High Net-Worth Individuals (HNIs). The reservation quota for each group has been strategically set to encourage participation and maintain compliance with market regulations.
|QIB Shares Offered
|Not more than 50%
|Retail Shares Offered
|Not less than 35%
|NII (HNI) Shares Offered
|Not less than 15%
For the RIIs, the draw is in the accessibility. With a set reservation of at least 35% of the Net Issue, retail investors are given a fair chance to participate. This aligns with the market ideal of promoting individual investors’ entry into the capital market. Innova Captab extends an opportunity for investors to own a part of a growing pharmaceutical company by initially setting aside a significant portion of its shares for retail participants.
On the flip side, NIIs encompass the more affluent investors, with a stipulation that at least 15% of the Net Issue is reserved for this category. This allocation prioritizes those with higher investment capacities, possibly ranging from corporate clients to savvy individual investors looking to expand their portfolios.
Lastly, the institutionally focused QIBs are allocated not more than 50% of the Net Issue. This sizable reservation is crucial, as these institutional investors often bring in the bulk of the capital in public offerings.
It’s important as an investor to understand the Innova Captab IPO’s reservation percentages. They emphasize the company’s commitment to a diverse shareholder base and equitable share distribution among different investing publics. Remember, the application process adheres to a tiered structure based on lot sizes, ensuring that investment opportunities are scalable and accessible across the spectrum of investor categories.
About Innova Captab Limited
Innova Captab Limited has carved a niche for itself in the pharmaceutical industry. As an integrated company, it’s involved in various aspects of the pharmaceutical value chain, including research and development, manufacturing of drugs, and effective distribution both domestically and internationally. Founded in 2011, the company has had over a decade to establish its foothold and innovate within the healthcare sector.
Operating out of Panchkula, Haryana, with a significant workforce of 1,001-5,000 employees, Innova Captab underscores the importance of skilled personnel in driving its ambitious vision. The firm boasts three state-of-the-art manufacturing facilities in Baddi, which adhere to stringent quality checks and are equipped with advanced technology, ensuring that all products meet global standards.
My research indicates that Innova Captab’s portfolio encompasses a wide range of products that cater to numerous therapeutic segments, reflecting the company’s commitment to comprehensive healthcare solutions. Its strategic presence across the entire supply chain gives it a competitive edge in not just meeting market demands but also in adapting swiftly to shifts within the pharmaceutical domain.
With the upcoming IPO set to open on December 21, 2023, potential investors should have Innova Captab on their radar. The management’s foresight in steering the company toward an IPO suggests a desire for scalable growth and an opportunity for the public to be a part of its expansion story. The company’s significant exports add an additional layer of intrigue, painting a picture of a business with a global vision.
Investors and market watchers alike can observe the IPO proceedings and leverage the data available on the company’s financial health, which can be accessed through their official website, providing transparency and insights into their operational success. The forward momentum of Innova Captab Limited is a testament to its robust business model and the potential for future growth in the dynamic pharmaceutical industry.
Innova Captab IPO Review
As I delve deeper into Innova Captab’s much-anticipated IPO, I’m compelled to highlight the noteworthy figures that investors should consider. This premier pharma company has paved its way to the public market with an impressive fresh issue of Rs 320 crore and an offer for sale of Rs 250 crore. With the price per equity share set between ₹426.00-448.00, it’s no wonder that there’s a buzz around this IPO.
Understanding the structure of an IPO is crucial, and Innova Captab’s allotment process reflects a balanced approach. Notably, the retail quota has been earmarked to account for no less than 35% of the net issue, enabling a wide spectrum of investors to get a slice of the pie. Each lot holds 33 shares, a manageable number that aligns with investment strategies of diverse scales.
Furthermore, versatility in subscription methods has been facilitated by the company. Opting for the UPI mode of payment when applying via physical forms adds a layer of convenience for potential shareholders. For those favoring a more digital approach, applying with net banking IDs through the ASBA process is a swift alternative. Efficiency in applications reflects Innova Captab’s commitment to modernization and investor inclusivity.
|Rs 320 Crore
|Offer for Sale
|Rs 250 Crore
|Face Value per Share
|₹426.00 – 448.00
|≥ 35% of Net Issue
The extensive coverage of Innova Captab’s IPO on platforms like 5paisa and InvestorGain further underscores its prominence. Analysts and seasoned investors are likely keeping an eye on the grey market premiums, which offer a sneak peek into the demand trajectory.
Innova Captab IPO Strengths and Weaknesses
As we look ahead to the Innova Captab Limited IPO, it’s clear that the buzz is well-founded. With a straightforward application process and strong interest reflected in the grey market, this IPO is poised to make significant waves in the market. It’s an exciting time for both the company and potential investors as the financial landscape brims with anticipation. Whether you’re a seasoned investor or considering your first foray into the stock market, keeping an eye on Innova Captab’s journey could be smart. Remember, thorough research and due diligence are key to making informed investment decisions. Let’s watch how this IPO unfolds and what it spells for the future of Innova Captab Limited.
How to Apply for Innova Captab IPO in Zerodha
To apply for the Innova Captab IPO through Zerodha, follow these steps:
- Ensure you are a Zerodha customer and have a UPI payment setup.
- Log in to the Zerodha Console on the Zerodha website or mobile app.
- Go to the Portfolio section and click on IPO.
- Select the Innova Captab IPO from the ongoing IPOs list and click “Apply.”
- Enter the UPI ID and the number of shares you want to apply for.
- Complete the payment process using UPI.
Please note that the IPO is open from December 21, 2023, to December 26, 2023. The minimum bid quantity is 10 shares, and the price band is not officially announced.